At a glance
ClinicalIndex Comparison Record- ✓Smoking 5 or more cigarettes per day
- ✓Age 18 years or older
- ✓Able to speak and read English
- ✓Eligible regardless of desire to quit smoking
- ✕Pregnancy
- ✕History of psychotic illness other than depression
- ✕Life expectancy less than 24 months
- ✕Dementia or incompetence for medical decision making
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Self-determination and Maintaining Tobacco Abstinence
In Brief
A Phase 4 clinical trial evaluating Self-determination Intervention for Tobacco Dependence for Tobacco Use Disorder. Completed, enrolled 837 participants across 1 site.
Detailed Summary
These two studies will examine the role of autonomous motivation in maintained adherence. The first study will determine whether smokers are still abstinent from tobacco 32 months after starting in a previous project (Smoker's Health Study). The purpose of the second study is to determine which of three treatments for tobacco dependence provides the greatest amount of protection from relapsing to smoking after quitting. Specifically, the investigators will determine if extending the length of treatment time focusing on relapse prevention and arranging for support from important others prevents relapse compared to community care. Also, the investigators will determine if providing extended treatment time and support from important others plus providing medications to those that don't want to quit prevents long term relapse compared to just extending the length of treatment time and support from others. Additionally, a sub set of the population will be randomized to using hand held palm devices to recover real-time data assessment during the last 10 months of the project.
Study Details
Timeline
Interventions
autonomy supported behavioral intervention for tobacco dependent individuals